BioNTech SE (BNTX) Receivables (2018 - 2025)

BioNTech SE (BNTX) has 8 years of Receivables data on file, last reported at $1.1 billion in Q4 2025.

• For the quarter ending Q4 2025, Receivables fell 31.23% year-over-year to $1.1 billion; the trailing twelve-month figure through Dec 2025 stood at $1.1 billion (down 31.23% YoY), and the FY2025 full-year result was $1.0 billion, down 33.25% from the prior year.
• Receivables improved to $1.1 billion in Q4 2025, from $807.6 million in the prior quarter.
• In the past five years, Receivables ranged from a high of $14.2 billion in Q1 2022 to a low of $5.3 million in Q4 2023.
• A 5-year average of $4.6 billion and a median of $2.0 billion in 2023 frame the typical range for Receivables.
• Peak annual rise in Receivables reached 29571.58% in 2024, while the deepest fall reached 97.18% in 2024.
• Tracing BNTX's Receivables over 5 years: stood at $14.2 billion in 2021, then slumped by 47.97% to $7.4 billion in 2022, then slumped by 99.93% to $5.3 million in 2023, then soared by 29571.58% to $1.6 billion in 2024, then slumped by 31.23% to $1.1 billion in 2025.
• Business Quant data shows BNTX's Receivables at $1.1 billion in Q4 2025, $807.6 million in Q3 2025, and $1.5 billion in Q2 2025.